Form 4: W.K. Kellogg Foundation Trust Sells Kellanova Shares

The W.K. Kellogg Foundation Trust executed a pre-planned sale of 114,599 shares of Kellanova common stock for approximately $9.1 million.

Summary

• The W.K. Kellogg Foundation Trust, identified as a 10% owner and having a director relationship with Kellanova, sold 114,599 shares of Kellanova common stock.
• The transaction occurred on August 28, 2025, with a deemed execution date on the same day.
• The shares were sold at a price of $79.5546 per share, totaling approximately $9,110,900.
• Following this transaction, the Trust beneficially owns 45,097,438 shares of Kellanova common stock.
• The sale was conducted pursuant to a Rule 10b5-1 trading plan, with instructions given on May 7, 2024.

Sentiment

Score: 5

Explanation: The sale by a significant shareholder is generally viewed as a slight negative, but the fact that it was pre-planned under a Rule 10b5-1 plan mitigates concerns that it is based on new, negative material non-public information. Therefore, the sentiment is neutral.

Positives

• The transaction was executed under a pre-arranged Rule 10b5-1 trading plan, indicating a scheduled sale rather than a reactive decision based on new, non-public information.

Negatives

• A significant shareholder, the W.K. Kellogg Foundation Trust, reduced its beneficial ownership in Kellanova by 114,599 shares.

Future Outlook

This Form 4 filing does not provide any forward-looking statements or guidance regarding Kellanova's future performance or strategic direction. It solely reports an insider transaction.

Management Comments

• Craig R. Carberry, Deputy General Counsel, The Northern Trust Company, signed as Corporate Trustee of the W.K. Kellogg Foundation Trust and for the W.K. Kellogg Foundation pursuant to a Power of Attorney dated August 30, 2017.

Industry Context

This filing reports a routine insider transaction by a major shareholder and does not contain information relevant to broader industry trends or competitive analysis.

Related Party Transactions

• The W.K. Kellogg Foundation Trust is identified as a 10% owner and has a director relationship with Kellanova, making this stock sale a transaction involving a related party.

Stakeholder Impact

• Shareholders may observe a reduction in the beneficial ownership of a major institutional investor, which could be interpreted in various ways depending on individual investment strategies.

Key Dates

Recommendation

While the sale by a significant shareholder could be seen as a negative signal, the fact that it was executed under a pre-arranged Rule 10b5-1 plan suggests it is not based on new, adverse information. Therefore, this single transaction alone does not warrant a change in investment recommendation, and a 'hold' stance is appropriate for existing investors, pending further fundamental analysis.

Keywords

Kellanova, K, W.K. Kellogg Foundation Trust, insider sale, Form 4, 10b5-1 plan, common stock, beneficial ownership